COMMON NAME |
SGN-35, cAC10-Val-Cit-MMAE |
---|---|
SYNONYMS |
TNFRSF8;D30;1S166E;i-1 |
APPLICATIONS |
ELISA |
RECOMMENDED DILUTIONS |
ELISA 1:5000-10000 |
FORMULATION & RECONSTITUTION |
Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
HOST SPECIES |
Chimeric |
IGG TYPE |
IgG1 |
REACTIVITY |
Human |
TARGET | |
UNIPROT ID |
P28908 |
DESCRIPTION |
Anti-CD30 (brentuximab biosimilar) mAb |
DELIVERY |
In Stock |
STORAGE & SHIPPING |
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
BACKGROUND |
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
USAGE |
Research use only |
SKU(재고 관리 코드):BME100017
Anti-CD30 (brentuximab biosimilar) mAb
Anti-CD30 (brentuximab biosimilar) mAb
PRODUCT DATA
IMAGES
Figure 1. ELISA plate pre-coated by 2 μg/ml (100 μl/well) Human CD30, His tagged protein (PME100481) can bind Anti-CD30 Neutralizing antibody in a linear range of 0.13-80.0 ng/ml.
Figure 2. Flow cytometry analysis with Anti-CD30 (brentuximab ) on Expi293 cells transfected with human CD30 (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).